| Product Code: ETC4633296 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Non-Oncology Precision Medicine Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Sweden Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Sweden Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Sweden Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 Sweden Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized treatment options in non-oncology medical conditions |
4.2.2 Technological advancements in precision medicine tools and techniques |
4.2.3 Supportive government initiatives and funding for precision medicine research in Sweden |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine treatments |
4.3.2 Limited awareness and understanding among healthcare professionals and patients about non-oncology precision medicine |
4.3.3 Regulatory challenges and data privacy concerns related to the implementation of precision medicine in Sweden |
5 Sweden Non-Oncology Precision Medicine Market Trends |
6 Sweden Non-Oncology Precision Medicine Market Segmentations |
6.1 Sweden Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2021-2031F |
6.1.3 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.4 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2021-2031F |
6.1.5 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2021-2031F |
6.1.6 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2021-2031F |
6.2 Sweden Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2021-2031F |
6.2.3 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2021-2031F |
6.2.4 Sweden Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2021-2031F |
7 Sweden Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Sweden Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Sweden Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Sweden Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Percentage of healthcare professionals trained in non-oncology precision medicine techniques |
8.2 Number of clinical trials focusing on non-oncology precision medicine conducted in Sweden |
8.3 Patient adoption rate of personalized treatment plans based on precision medicine recommendations |
8.4 Rate of successful outcomes and improved patient health through non-oncology precision medicine interventions |
8.5 Investment and funding trends in non-oncology precision medicine research and development in Sweden |
9 Sweden Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Sweden Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Sweden Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 Sweden Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Sweden Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2024 |
10.2 Sweden Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here